Notably, while LKB1/AMPK signaling typically acts as a barrier to tumorigenesis by maintaining energy balance and inhibiting mTOR activity, its dysregulation can also confer survival advantages on cancer cells, particularly in the nutrient-deprived tumor microenvironment. This evidence concerns the gene STK11 and neoplasm.